Sourcebio International PLC
LSE:SBI
Sourcebio International PLC
LSE:SBI
Price:
115 GBX
4.55%
Market Closed
Updated:
May 16, 2024
Sourcebio International PLC
Cost of Revenue
|
Sourcebio International PLC
Cost of Revenue Peer Comparison
Comparables:
KOO
G
GENI
TLY
T
TRLS
MGP
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sourcebio International PLC
LSE:SBI
|
Cost of Revenue
-£56.2m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kooth PLC
LSE:KOO
|
Cost of Revenue
-£7.5m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
G
|
Genincode PLC
LSE:GENI
|
Cost of Revenue
-£798k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Totally PLC
LSE:TLY
|
Cost of Revenue
-£98.4m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
T
|
Trellus Health PLC
LSE:TRLS
|
Cost of Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medica Group PLC
LSE:MGP
|
Cost of Revenue
-£39.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
See Also
What is Sourcebio International PLC's Cost of Revenue?
Cost of Revenue
-56.2m
GBP
-56.2m
GBP
Based on the financial report for Dec 31, 2021, Sourcebio International PLC's Cost of Revenue amounts to -56.2m GBP.
What is Sourcebio International PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-60%
-60%
Over the last year, the Cost of Revenue growth was -86%. The average annual Cost of Revenue growth rates for Sourcebio International PLC have been -60% over the past three years .
You don't have any saved screeners yet
